BACKGROUND: @entity955 ( @entity955 ) can be managed with rhythm- or rate-control strategies. There are few data from routine clinical practice on the frequency with which each strategy is used and their correlates in terms of @entity1 ' clinical characteristics, @entity955 control, and symptom burden. METHODS: RealiseAF was an international, cross-sectional, observational survey of 11,198 @entity1 with @entity955 . The aim of this analysis was to describe @entity1 profiles and symptoms according to the @entity955 management strategy used. A multivariate logistic regression identified factors associated with @entity955 management strategy at the end of the visit. RESULTS: Among 10,497 eligible @entity1 , 53.7% used a rate-control strategy, compared with 34.5% who used a rhythm-control strategy. In 11.8% of @entity1 , no clear strategy was stated. The proportion of @entity1 with @entity955 -related symptoms (EHRA Class > = II) was 78.1% (n = 4396/5630) for those using a rate-control strategy vs. 67.8% for those using a rhythm-control strategy (p<0.001). Multivariate logistic regression analysis revealed that age <75 years or the paroxysmal or persistent form of @entity955 favored the choice of a rhythm-control strategy. A change in strategy was infrequent, even in @entity1 with European Heart Rhythm Association (EHRA) Class > = II. CONCLUSIONS: In the RealiseAF routine clinical practice survey, rate control was more commonly used than rhythm control, and a change in strategy was uncommon, even in symptomatic @entity1 . In almost 12% of @entity1 , no clear strategy was stated. Physician awareness regarding optimal management strategies for @entity955 may be improved.

XXXX Management Strategies in Routine Clinical Practice: Insights from the International RealiseAF Survey.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity955 :: ('MESH:D001281', 'Disease') :: ['Atrial fibrillation', 'AF']
@entity955 :: (MESH:D001281,Disease) :: ['Atrial Fibrillation']
